MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Determinants of balance confidence and concern about falling in people with Parkinson’s disease

    L. Almeida, G. Valenca, E. Pinto, J. Oliveira-Filho (Salvador, Brazil)

    Objective: To identify factors that contribute to balance confidence and concern about falling in people with Parkinson’s disease (PD). Background: Reduced balance confidence and greater…
  • 2017 International Congress

    Parkinsonics – A Prospective, Randomized, Blinded, Cross-Over Trial of Group Singing for Motor and Non-Motor Symptoms in Idiopathic Parkinson Disease (PD)

    A. Butala, A. Swaminathan, S. Dunlop, Y. Salnikova, B. Ficek, B. Portnoff, M. Harper, B. Vernon, Z. Mari, A. Pantelyat (Baltimore, MD, USA)

    Objective: To assess the effects of weekly group singing on PD patients’ objective vocal and motoric function, cognition, mood, self-efficacy and quality of life. Background:…
  • 2017 International Congress

    Evaluating the Experience of Diagnosis in Parkinson’s Disease

    A. Robinson, E. Pearson, F. Murphy, J. Davis, C. Carroll (Plymouth, United Kingdom)

    Objective: To evaluate a newly-designed diagnosis patient pathway for Parkinson’s disease, in terms of quality measures and patient satisfaction. Background: Receiving a diagnosis of Parkinson’s…
  • 2017 International Congress

    Efficacy of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in patients with Parkinson’s disease:  results from the Phase 3 study dose-titration phase

    R. Hauser, S. Isaacson, A. Espay, R. Pahwa, D. Truong, E. Pappert, P. Gardzinski, B. Dzyngel, A. Agro, H. Fernandez (Tampa, FL, USA)

    Objective: To determine the dose of APL-130277 required by each patient with Parkinson’s Disease (PD) to turn from OFF to Full ON.  This dose is…
  • 2017 International Congress

    Intensive Short-Term Dance Intervention in Parkinson’s Disease

    D. Rabinovich, J. DeSouza, T. Arakaki, S. Rodriguez Quiroga, V. Litvak, J. Firmani, N. Garreto (Toronto, ON, Canada)

    Objective: To evaluate changes in motor symptoms and quality of life for people with Parkinson’s disease (PD) as a result of an intensive short-term dance intervention. …
  • 2017 International Congress

    Multi-modal retention in a phase III clinical trial in early Parkinson disease (STEADY-PD III)

    B. Greco, T. Simuni, J. Denmark, S. Henderson, J. Lowell, S. Sharma, C. Tarolli, D. Young, K. Biglan (Rochester, NY, USA)

    Objective: To evaluate novel retention strategies in an ongoing phase 3 clinical trial in individuals with Parkinson disease (PD) Background: Adequate participant retention is a…
  • 2017 International Congress

    Associating patient impression of improvement with efficacy endpoints in Parkinson’s disease: A post-hoc analysis of a tozadenant study

    C. Kenney, A. Glass, W. Olanow (Ardsley, NY, USA)

    Objective: To evaluate whether patient perceived improvement of Parkinson’s disease (PD) symptoms was associated with improvement in efficacy endpoints (mean daily OFF time and ON…
  • 2017 International Congress

    99mTc-TRODAT-1 SPECT imaging in early and late onset Parkinson’s disease.

    A. Ghabeli Juibary, V.R. Dabbagh Kakhki, P. Sasannejad, R. Sadeghi, K. Sadri, M. Sabour, H. Alizadeh (Mashhad, Islamic Republic of Iran)

    Objective: In this study we tried to determine  the TRODAT SPECT findings in EOPD  as compared to LOPD. Background: 99mTc-TRODAT-1, which binds to the dopamine…
  • 2017 International Congress

    The effect of expectation on Parkinson’s Disease: an EEG study

    E. Carlino, A. Piedimonte, G. Guerra, A. Romagnolo, E. Frisaldi, S. Vighetti, L. Lopiano (Turin, Italy)

    Objective: The aim of the present study is to determine how the expectation of receiving a therapeutic treatment influences Parkinson’s disease (PD) symptoms. Background: The…
  • 2017 International Congress

    The prevalence of cerebral microbleeds in patients with Parkinson’s disease and multiple system atrophy

    J.-M. Kim (Seongnam, Republic of Korea)

    Objective: Here, we compared the prevalence of cerebral microbleeds (CMBs) in patients with parkinsonian disorders, including Parkinson’s diseaseParkinson’s disease (PD) and multiple system atrophy (MSA).…
  • « Previous Page
  • 1
  • …
  • 309
  • 310
  • 311
  • 312
  • 313
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley